01 1CARBOGEN AMCIS AG
02 1MSN Laboratories Private Limited
01 2Pemigatinib
01 1India
02 1Switzerland
NDC Package Code : 58567-108
Start Marketing Date : 2023-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0505
Start Marketing Date : 2023-11-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
41
PharmaCompass offers a list of Pemigatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pemigatinib manufacturer or Pemigatinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pemigatinib manufacturer or Pemigatinib supplier.
PharmaCompass also assists you with knowing the Pemigatinib API Price utilized in the formulation of products. Pemigatinib API Price is not always fixed or binding as the Pemigatinib Price is obtained through a variety of data sources. The Pemigatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pemigatinib (Proposed Inn) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pemigatinib (Proposed Inn), including repackagers and relabelers. The FDA regulates Pemigatinib (Proposed Inn) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pemigatinib (Proposed Inn) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pemigatinib (Proposed Inn) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pemigatinib (Proposed Inn) supplier is an individual or a company that provides Pemigatinib (Proposed Inn) active pharmaceutical ingredient (API) or Pemigatinib (Proposed Inn) finished formulations upon request. The Pemigatinib (Proposed Inn) suppliers may include Pemigatinib (Proposed Inn) API manufacturers, exporters, distributors and traders.
click here to find a list of Pemigatinib (Proposed Inn) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pemigatinib (Proposed Inn) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pemigatinib (Proposed Inn) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pemigatinib (Proposed Inn) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pemigatinib (Proposed Inn) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pemigatinib (Proposed Inn) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pemigatinib (Proposed Inn) suppliers with NDC on PharmaCompass.
We have 2 companies offering Pemigatinib (Proposed Inn)
Get in contact with the supplier of your choice:
